MARKET

AMPH

AMPH

Amphastar Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.34
-0.06
-0.29%
After Hours 16:06 08/14 EDT
OPEN
20.38
PREV CLOSE
20.40
HIGH
20.50
LOW
20.09
VOLUME
169.14K
TURNOVER
--
52 WEEK HIGH
22.85
52 WEEK LOW
12.33
MARKET CAP
965.86M
P/E (TTM)
248.05
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMPH stock price target is 22.40 with a high estimate of 24.00 and a low estimate of 20.00.

EPS

AMPH News

More
Amphastar Pharmaceuticals' (AMPH) Management on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/08 15:34
Amphastar Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with their 2020 Q2 earnings call.
Seekingalpha · 08/07 21:17
Amphastar Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with their 2020 Q2 earnings call.
Seekingalpha · 08/07 21:17
Amphastar Pharmaceuticals EPS beats by $0.02, misses on revenue
Amphastar Pharmaceuticals (NASDAQ:AMPH): Q2 Non-GAAP EPS of $0.16 beats by $0.02; GAAP EPS of $0.00. Revenue of $85.81M (+8.6% Y/Y) misses by $0.81M. Press
seekingalpha · 08/07 01:16
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
Reports Net Revenues of $85.8 Million for the Three Months Ended June 30, 2020RANCHO CUCAMONGA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three months
GlobeNewswire · 08/06 20:05
Amphastar Pharmaceuticals's Earnings: A Preview
On Thursday, August 06, Amphastar Pharmaceuticals (NASDAQ: AMPH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Analysts expect Amphastar Pharmaceuticals earnings
Benzinga · 08/05 16:18
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020, after the market closes on Thursday, August 6th, 2020
GlobeNewswire · 07/30 20:05
Amphastar Pharmaceuticals (AMPH) Earnings Expected to Grow: Should You Buy?
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33

Industry

Pharmaceuticals
-0.37%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Symbol
Price
%Change

About AMPH

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
More

Webull offers kinds of Amphastar Pharmaceuticals Inc stock information, including NASDAQ:AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMPH stock methods without spending real money on the virtual paper trading platform.